全文获取类型
收费全文 | 15362篇 |
免费 | 1058篇 |
国内免费 | 109篇 |
专业分类
耳鼻咽喉 | 134篇 |
儿科学 | 465篇 |
妇产科学 | 454篇 |
基础医学 | 2414篇 |
口腔科学 | 272篇 |
临床医学 | 1245篇 |
内科学 | 3531篇 |
皮肤病学 | 376篇 |
神经病学 | 2199篇 |
特种医学 | 418篇 |
外科学 | 1433篇 |
综合类 | 28篇 |
一般理论 | 1篇 |
预防医学 | 817篇 |
眼科学 | 167篇 |
药学 | 1093篇 |
中国医学 | 32篇 |
肿瘤学 | 1450篇 |
出版年
2023年 | 189篇 |
2022年 | 168篇 |
2021年 | 527篇 |
2020年 | 395篇 |
2019年 | 480篇 |
2018年 | 634篇 |
2017年 | 471篇 |
2016年 | 518篇 |
2015年 | 593篇 |
2014年 | 731篇 |
2013年 | 968篇 |
2012年 | 1389篇 |
2011年 | 1392篇 |
2010年 | 778篇 |
2009年 | 707篇 |
2008年 | 1167篇 |
2007年 | 1057篇 |
2006年 | 958篇 |
2005年 | 852篇 |
2004年 | 779篇 |
2003年 | 689篇 |
2002年 | 526篇 |
2001年 | 54篇 |
2000年 | 33篇 |
1999年 | 53篇 |
1998年 | 82篇 |
1997年 | 53篇 |
1996年 | 37篇 |
1995年 | 41篇 |
1994年 | 44篇 |
1993年 | 22篇 |
1992年 | 18篇 |
1991年 | 18篇 |
1990年 | 16篇 |
1989年 | 15篇 |
1988年 | 7篇 |
1987年 | 10篇 |
1986年 | 10篇 |
1985年 | 8篇 |
1984年 | 6篇 |
1983年 | 5篇 |
1982年 | 6篇 |
1981年 | 5篇 |
1980年 | 7篇 |
1979年 | 4篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1974年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Nicla La Verde Agostino Riva Maria Silvia Cona Arianna Gabrieli Monica Cattaneo Cinzia Fasola Giuseppe Lipari Claudia De Stradis Valentina Favorito Benedetta Lombardi Stocchetti Davide Chizzoniti Alice Covizzi Eliana Rulli Francesca Galli Lorenzo Ruggieri Anna Gambaro Sabrina Ferrario Davide Dalu Maciej S. Tarkowski 《International journal of cancer. Journal international du cancer》2023,152(4):661-671
Previous studies on the immunogenicity of SARS-CoV-2 mRNA vaccines showed a reduced seroconversion in cancer patients. The aim of our study is to evaluate the immunogenicity of two doses of mRNA vaccines in solid cancer patients with or without a previous exposure to the virus. This is a single-institution, prospective, nonrandomized study. Patients in active treatment and a control cohort of healthy people received two doses of BNT162b2 (Comirnaty, BioNTech/Pfizer, The United States) or mRNA-1273 (Spikevax, Moderna). Vaccine was administered before starting anticancer therapy or on the first day of the treatment cycle. SARS-CoV-2 antibody levels against S1, RBD (to evaluate vaccine response) and N proteins (to evaluate previous infection) were measured in plasma before the first dose and 30 days after the second one. From January to June 2021, 195 consecutive cancer patients and 20 healthy controls were enrolled. Thirty-one cancer patients had a previous exposure to SARS-CoV-2. Cancer patients previously exposed to the virus had significantly higher median levels of anti-S1 and anti-RBD IgG, compared to healthy controls (P = .0349) and to cancer patients without a previous infection (P < .001). Vaccine type (anti-S1: P < .0001; anti-RBD: P = .0045), comorbidities (anti-S1: P = .0274; anti-RBD: P = .0048) and the use of G-CSF (anti-S1: P = .0151) negatively affected the antibody response. Conversely, previous exposure to SARS-CoV-2 significantly enhanced the response to vaccination (anti-S1: P < .0001; anti-RBD: P = .0026). Vaccine immunogenicity in cancer patients with a previous exposure to SARS-CoV-2 seems comparable to that of healthy subjects. On the other hand, clinical variables of immune frailty negatively affect humoral immune response to vaccination. 相似文献
2.
Antonia Valeria Borraccino Francesca Celiberto Maria Pricci Bruna Girardi rea Iannone Maria Rendina Enzo Ierardi Alfredo Di Leo Giuseppe Losurdo 《World journal of gastroenterology : WJG》2022,28(45):6356-6362
When several Helicobacter pylori eradication treatments fail, guidelines recommend a cultured guided approach; however, culture is not widely available. Therefore, a rifabutin based regimen could be the best solution. Rifabutin indeed shows a low rate of antibiotic resistance. Rifabutin is generally used in combination with amoxicillin in a triple therapy, with eradication rates about 80% in third-line regimens. The ideal duration of this therapy should range between 10 and 12 d. Combinations with antibiotics other than amoxicillin have demonstrated even better results, such as vonoprazan, which is a type of novel acid suppressor drug. Finally, a new formulation of triple therapy in a single capsule is under investigation, which is a field that deserves further investigation. Some notes of caution about rifabutin should be mentioned. This drug is used to treat tuberculosis or atypical mycobacteria; therefore, before starting a rifabutin-based eradication regimen, Mycobacterium tuberculosis infection should be thoroughly tested, since its use could promote the development of antibiotic resistance, thus affecting its effectiveness against Koch’s bacillus. Additionally, some serious side effects must be evaluated before starting any rifabutin-based therapy. Adverse effects include fever, nausea, vomiting and bone marrow suppression. For this reason, full blood count surveillance is required. 相似文献
3.
Giuseppina Daniela Naimo Martina Forestiero Alessandro Paolì Rocco Malivindi Luca Gelsomino Balázs Győrffy Adele Elisabetta Leonetti Francesca Giordano Salvatore Panza Francesca Luisa Conforti Paola Ruffo Maria Luisa Panno Loredana Mauro Sebastiano Andò 《International journal of cancer. Journal international du cancer》2023,153(6):1257-1272
Adiponectin is the major adipocytes-secreted protein involved in obesity-related breast cancer growth and progression. We proved that adiponectin promotes proliferation in ERα-positive breast cancer cells, through ERα transactivation and the recruitment of LKB1 as ERα-coactivator. Here, we showed that adiponectin-mediated ERα transactivation enhances E-cadherin expression. Thus, we investigated the molecular mechanism through which ERα/LKB1 complex may modulate the expression of E-cadherin, influencing tumor growth, progression and distant metastasis. We demonstrated that adiponectin increases E-cadherin expression in ERα-positive 2D and higher extent in 3D cultures. This occurs through a direct activation of E-cadherin gene promoter by ERα/LKB1-complex. The impact of E-cadherin on ERα-positive breast cancer cell proliferation comes from the evidence that in the presence of E-cadherin siRNA the proliferative effects of adiponectin is no longer noticeable. Since E-cadherin connects cell polarity and growth, we investigated if the adiponectin-enhanced E-cadherin expression could influence the localization of proteins cooperating in cell polarity, such as LKB1 and Cdc42. Surprisingly, immunofluorescence showed that, in adiponectin-treated MCF-7 cells, LKB1 and Cdc42 mostly colocalize in the nucleus, impairing their cytosolic cooperation in maintaining cell polarity. The orthotopic implantation of MCF-7 cells revealed an enhanced E-cadherin-mediated breast cancer growth induced by adiponectin. Moreover, tail vein injection of MCF-7 cells showed a higher metastatic burden in the lungs of mice receiving adiponectin-treated cells compared to control. From these findings it emerges that adiponectin treatment enhances E-cadherin expression, alters cell polarity and stimulates ERα-positive breast cancer cell growth in vitro and in vivo, sustaining higher distant metastatic burden. 相似文献
4.
5.
Canosa Stefano Parmegiani Lodovico Charrier Lorena Gennarelli Gianluca Garello Cristina Granella Francesca Evangelista Francesca Monelli Giuseppe Guidetti Daniela Revelli Alberto Filicori Marco Bongioanni Francesca 《Journal of assisted reproduction and genetics》2022,39(1):67-73
Journal of Assisted Reproduction and Genetics - To study whether a new combination of different warming kits is clinically effective for vitrified human blastocysts. This is a longitudinal cohort... 相似文献
6.
Bixio Riccardo Bertelle Davide Pistillo Francesca Pedrollo Elisa Carletto Antonio Rossini Maurizio Viapiana Ombretta 《Clinical rheumatology》2022,41(4):1247-1254
Clinical Rheumatology - Myasthenia gravis is an autoimmune disease affecting the neuromuscular junction, often associated with other autoimmune diseases, including rheumatoid arthritis. Patients... 相似文献
7.
Lucarini Valeria Cangemi Francesco Daniel Benyamin Daniel Lucchese Jacopo Paraboschi Francesca Cattani Chiara Marchesi Carlo Grice Martine Vogeley Kai Tonna Matteo 《European archives of psychiatry and clinical neuroscience》2022,272(6):997-1005
European Archives of Psychiatry and Clinical Neuroscience - Difficulties in interpersonal communication, including conversational skill impairments, are core features of schizophrenia. However,... 相似文献
8.
9.
Andrea Spinazzè Andrea Cattaneo Francesca Borghi Luca Del Buono Davide Campagnolo Sabrina Rovelli Domenico M. Cavallo 《International journal of hygiene and environmental health》2019,222(1):76-83
An experimental probabilistic approach for health risk assessment was applied for graphene nanoplatelets (GNPs). The hazard assessment indicated a low level of toxicity for the GNPs. The benchmark dose method, based on sub-chronic and chronic inhalation exposure studies, was used to quantify a guidance value (BMCh) for occupational inhalation exposure to GNPs, expressed as a lognormal distribution with a geometric mean?±?geometric standard deviation of 0.212?±?7.79?mg/m3 and 9.37?×?104?±?7.6 particle/cm3. Exposure scenarios (ES) were defined based on the scientific literature for large-scale production (ES1) and manufacturing (ES2) of GNPs; a third ES, concerning in-lab handling of GNPs (ES3) was based on results of experiments performed for this study. A probability distribution function was then assumed for each ES. The risk magnitude was calculated using a risk characterization ratio (RCR), defined as the ratio of the exposure distributions and the BMCh distribution. All three ES resulted in RCR distributions ≥1 (i.e. risk present); however, none of the ES had a statistically significant level of risk at a 95% confidence interval. A sensitivity analysis indicated that ~75% of the variation in the RCR distributions was due to uncertainties in the BMCh calculation. 相似文献
10.